EcoDrugPlus

Protein Kinase C Theta Type-Like

Ensembl ID : ENSSTUG00000016485
Gene Symbol: LOC115198847
3 Cross references
201 Possible Orthologues:

Protein Kinase C Theta Type-Like

Ensembl ID : ENSSTUG00000051013
Gene Symbol: LOC115180286
3 Cross references
201 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSSTUG00000027538
Gene Symbol: PRKCZ
3 Cross references
195 Possible Orthologues:

Protein Kinase C Zeta Type-Like

Ensembl ID : ENSSTUG00000017660
Gene Symbol: LOC115165374
3 Cross references
194 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSSTUG00000023501
Gene Symbol: PRKD1
3 Cross references
198 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSSTUG00000007616
Gene Symbol: PRKD1
3 Cross references
198 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSSTUG00000050017
Gene Symbol: PRKD3
3 Cross references
203 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSSTUG00000034207
Gene Symbol: PRKD3
3 Cross references
195 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSSTUG00000026310
Gene Symbol: PRKD3
3 Cross references
195 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSSTUG00000027407
Gene Symbol: PRKD3
3 Cross references
203 Possible Orthologues:

Protein Mono-Adp-Ribosyltransferase Parp3-Like

Ensembl ID : ENSSTUG00000033963
Gene Symbol: LOC115147802
3 Cross references
192 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSSTUG00000035269
Gene Symbol: PPP3CA
3 Cross references
228 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).